Literature DB >> 35221766

Precancerous Pyloric Gland Metaplasia in the Biliary Epithelium Associated with Congenital Biliary Dilatation in a Three-Month-Old Infant.

Shuichi Takano1, Toshimichi Hasegawa1, Kohga Masuda1, Takehiko Hanaki1, Naruo Tokuyasu1, Teruhisa Sakamoto1, Kanae Nosaka2, Yoshiyuki Fujiwara1.   

Abstract

Pyloric gland metaplasia in the biliary epithelium is a precancerous lesion and has been confirmed in patients with congenital biliary dilatation presenting with overt biliary tract cancer. A patient was found to have an intra-abdominal cyst on fetal ultrasonography and was born at 37 weeks of gestation with a body weight of 2,636 g. Abdominal distension and repeated vomiting appeared 2 days after birth. Congenital biliary dilatation was diagnosed by imaging, wherein the common bile duct was enlarged to 9-10 cm in size, and the surrounding organs were extensively compressed; however, there was no sign of pancreatitis or cholangitis. Biliary drainage was performed through the gallbladder at 6 days of age, but it was insufficient because of the narrow and twisted cystic duct and changed to common bile duct at 18 days to relieve the compression. Because the body weight gain was poor due to loss of large amount of bile, the dilated bile duct and gallbladder were resected and hepatic duct Roux-Y jejunostomy was performed at 115 days of age with 4,500 g of body weight. Intraoperative imaging showed a pancreaticobiliary maljunction, and the pancreatic enzyme activities of the bile in the biliary system were remarkably elevated. Histopathological examination revealed pyloric gland metaplasia in the gallbladder epithelium and cystic duct. The patient is now over 2 years old and has been doing well without any complications. Based on our experience, precancerous pyloric gland metaplasia of the biliary epithelium may already occur even in a 3-month-old infant presenting with congenital biliary dilatation. ©2022 Tottori University Medical Press.

Entities:  

Keywords:  biliary tract cancer; congenital biliary dilatation; pancreaticobiliary maljunction; precancerous lesion; pyloric gland metaplasia

Year:  2022        PMID: 35221766      PMCID: PMC8857673          DOI: 10.33160/yam.2022.02.007

Source DB:  PubMed          Journal:  Yonago Acta Med        ISSN: 0513-5710            Impact factor:   1.641


  24 in total

1.  Mucosal changes of the gallbladder in anomalous union with the pancreatico-biliary duct system.

Authors:  M Yamamoto; S Nakajo; E Tahara; M Ito; K Taniyama; F Shimamoto; N Miyoshi; Y Hayashi; H Akiyama; S Nakai
Journal:  Pathol Res Pract       Date:  1991-03       Impact factor: 3.250

Review 2.  Pancreaticobiliary maljunction.

Authors:  Terumi Kamisawa; Kensuke Takuma; Hajime Anjiki; Naoto Egawa; Masanao Kurata; Goro Honda; Kouji Tsuruta; Tsuneo Sasaki
Journal:  Clin Gastroenterol Hepatol       Date:  2009-11       Impact factor: 11.382

3.  Lysophosphatidylcholine suppresses apoptotic cell death by inducing cyclooxygenase-2 expression via a Raf-1 dependent mechanism in human cholangiocytes.

Authors:  G-Y Gwak; J-H Yoon; S-H Lee; S-M Lee; H-S Lee; G J Gores
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-29       Impact factor: 4.553

4.  Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy.

Authors:  D A Lieberman; M Oehlke; M Helfand
Journal:  Am J Gastroenterol       Date:  1997-08       Impact factor: 10.864

5.  Histologic and genetic analysis of the gallbladder in patients with occult pancreatobiliary reflux.

Authors:  Takao Itoi; Akihiko Tsuchida; Fumihide Itokawa; Atsushi Sofuni; Toshio Kurihara; Takayoshi Tsuchiya; Fuminori Moriyasu; Kazuhiko Kasuya; Hiromi Serizawa
Journal:  Int J Mol Med       Date:  2005-03       Impact factor: 4.101

Review 6.  Gallbladder cancer: lessons from a rare tumour.

Authors:  Ignacio I Wistuba; Adi F Gazdar
Journal:  Nat Rev Cancer       Date:  2004-09       Impact factor: 60.716

7.  Pathologic changes in the non-carcinomatous epithelium of the gallbladder in patients with a relatively long common channel.

Authors:  Terumi Kamisawa; Nobuaki Funata; Yukiko Hayashi; Naoto Egawa; Hitoshi Nakajima; Kouji Tsuruta; Atsutake Okamoto; Toshikazu Yamaguchi
Journal:  Gastrointest Endosc       Date:  2004-07       Impact factor: 9.427

8.  K-ras and p53 gene mutations in noncancerous biliary lesions of patients with pancreaticobiliary maljunction.

Authors:  Toshiki Matsubara; Yoichi Sakurai; Li-Zhu Zhi; Hirotake Miura; Masahiro Ochiai; Takahiko Funabiki
Journal:  J Hepatobiliary Pancreat Surg       Date:  2002

9.  Pancreatobiliary reflux in individuals with a normal pancreaticobiliary junction: a prospective multicenter study.

Authors:  Jun Horaguchi; Naotaka Fujita; Terumi Kamisawa; Goro Honda; Kazuo Chijiiwa; Hiroyuki Maguchi; Masao Tanaka; Mitsuo Shimada; Yoshinori Igarashi; Kazuo Inui; Keiji Hanada; Takao Itoi; Yoshinori Hamada; Tsugumichi Koshinaga; Hideki Fujii; Naoto Urushihara; Hisami Ando
Journal:  J Gastroenterol       Date:  2013-06-05       Impact factor: 7.527

10.  Clinical features of pancreaticobiliary maljunction: update analysis of 2nd Japan-nationwide survey.

Authors:  Yuji Morine; Mitsuo Shimada; Hideo Takamatsu; Tatsuo Araida; Itaru Endo; Masayuki Kubota; Akira Toki; Takuo Noda; Toshinobu Matsumura; Shuichi Miyakawa; Hiroki Ishibashi; Terumi Kamisawa; Hiroshi Shimada
Journal:  J Hepatobiliary Pancreat Sci       Date:  2013-06       Impact factor: 7.027

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.